HealthInvest Partners’s Insmed INSM Stock Holding History

HealthInvest Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.22M	Sell	58,378 -39,060	-40%	-$4.73M	1.67%	26
2026 Q1	$5.96M	Buy	97,438 +69,565	+250%	+$10.7M	1.92%	25
2025 Q4	$4.85M	Buy	+27,873	New	+$5.09M	1.55%	25

Other funds holding INSM

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

MCM

McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return

HealthInvest Partners's INSM Position: Q2 2026 in Review

HealthInvest Partners reduced its Insmed (INSM) stake by 40% in Q2 2026, selling an estimated $4.73M and leaving 58,378 shares worth $6.22M. The position accounts for 1.67% of the portfolio, ranked #26.

HealthInvest Partners first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. 159 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

HealthInvest Partners held 58,378 shares of Insmed worth $6.22M as of Q2 2026.
HealthInvest Partners sold 39,060 Insmed shares in Q2 2026, an estimated $4.73M.
Insmed made up 1.67% of HealthInvest Partners's portfolio in Q2 2026, its #26 holding.
HealthInvest Partners first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
159 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.